Mediterranean diet is associated with a lower probability of prodromal Parkinson's disease and risk for Parkinson's disease/dementia with Lewy bodies: A longitudinal study.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
04 2023
Historique:
revised: 14 01 2023
received: 21 07 2022
accepted: 18 01 2023
pubmed: 25 1 2023
medline: 8 3 2023
entrez: 24 1 2023
Statut: ppublish

Résumé

Lifestyle factors have been implicated in the long-lasting neurodegenerative process in prodromal Parkinson's disease (pPD). The aim was to investigate the associations between adherence to a Mediterranean diet (MeDi) and longitudinal changes of pPD probability and the development of Parkinson's disease (PD) or pPD in a Mediterranean older population. Data from the Hellenic Longitudinal Investigation of Aging and Diet cohort (community-dwelling individuals, aged ≥ 65 years) were used. A detailed food frequency questionnaire was used to evaluate dietary intake and calculate MeDi adherence score, ranging from 0 to 55, with higher scores indicating higher adherence. The probability of pPD was calculated according to the updated Movement Disorder Society research criteria. In all, 1047 non-PD/dementia with Lewy bodies (DLB) participants were followed for 3 ± 1 years. MeDi adherence was associated with lower increase in pPD probability over time (b = -0.003, 95% confidence interval -0.006 to -0.001, p = 0.010). Forty-nine participants had incident possible/probable pPD (i.e., pPD probability ≥ 30%). Compared to the participants in the lowest quartile of MeDi adherence, those in the higher quartiles had an approximately 60%-70% lower risk for possible/probable pPD (p for trend 0.003). MeDi-pPD associations were driven by both motor and non-motor pPD markers and not from risk markers. Also, 21 participants were diagnosed with PD/DLB at follow-up. For each unit increase in the MeDi score, there was a 9%-10% lower risk for PD/DLB (hazard ratio 0.906 [95% confidence interval 0.823-0.997], p = 0.044). Mediterranean diet adherence is associated with lower increase in pPD probability over time and lower possible/probable pPD and PD/DLB incidence in older Mediterranean people. More studies are needed to confirm our results in other populations.

Sections du résumé

BACKGROUND AND PURPOSE
Lifestyle factors have been implicated in the long-lasting neurodegenerative process in prodromal Parkinson's disease (pPD). The aim was to investigate the associations between adherence to a Mediterranean diet (MeDi) and longitudinal changes of pPD probability and the development of Parkinson's disease (PD) or pPD in a Mediterranean older population.
METHODS
Data from the Hellenic Longitudinal Investigation of Aging and Diet cohort (community-dwelling individuals, aged ≥ 65 years) were used. A detailed food frequency questionnaire was used to evaluate dietary intake and calculate MeDi adherence score, ranging from 0 to 55, with higher scores indicating higher adherence. The probability of pPD was calculated according to the updated Movement Disorder Society research criteria.
RESULTS
In all, 1047 non-PD/dementia with Lewy bodies (DLB) participants were followed for 3 ± 1 years. MeDi adherence was associated with lower increase in pPD probability over time (b = -0.003, 95% confidence interval -0.006 to -0.001, p = 0.010). Forty-nine participants had incident possible/probable pPD (i.e., pPD probability ≥ 30%). Compared to the participants in the lowest quartile of MeDi adherence, those in the higher quartiles had an approximately 60%-70% lower risk for possible/probable pPD (p for trend 0.003). MeDi-pPD associations were driven by both motor and non-motor pPD markers and not from risk markers. Also, 21 participants were diagnosed with PD/DLB at follow-up. For each unit increase in the MeDi score, there was a 9%-10% lower risk for PD/DLB (hazard ratio 0.906 [95% confidence interval 0.823-0.997], p = 0.044).
CONCLUSIONS
Mediterranean diet adherence is associated with lower increase in pPD probability over time and lower possible/probable pPD and PD/DLB incidence in older Mediterranean people. More studies are needed to confirm our results in other populations.

Identifiants

pubmed: 36692092
doi: 10.1111/ene.15698
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

934-942

Subventions

Organisme : Alzheimer's Association
ID : IIRG-09-133014
Pays : United States

Informations de copyright

© 2023 European Academy of Neurology.

Références

Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 2016;167(6):1469-1480.e1412.
Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M. Nutritional habits, risk, and progression of Parkinson disease. J Neurol. 2017;265:12-23.
Stocchi F, Torti M. Constipation in Parkinson's disease. Int Rev Neurobiol. 2017;134:811-826.
Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord. 2012;27(6):771-774.
Metcalfe-Roach A, Yu AC, Golz E, et al. MIND and Mediterranean diets associated with later onset of Parkinson's disease. Mov Disord. 2021;36(4):977-984.
Yin W, Löf M, Pedersen NL, Sandin S, Fang F. Mediterranean dietary pattern at middle age and risk of Parkinson's disease: a Swedish cohort study. Mov Disord. 2021;36(1):255-260.
Molsberry S, Bjornevik K, Hughes KC, Healy B, Schwarzschild M, Ascherio A. Diet pattern and prodromal features of Parkinson disease. Neurology. 2020;95(15):e2095-e2108.
Mitsou EK, Kakali A, Antonopoulou S, et al. Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population. Br J Nutr. 2017;117(12):1645-1655.
De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65(11):1812-1821.
Sureda A, Bibiloni MDM, Julibert A, et al. Adherence to the Mediterranean diet and inflammatory markers. 2018;10(1):62.
Hart MJ, Torres SJ, McNaughton SA, Milte CM. Dietary patterns and associations with biomarkers of inflammation in adults: a systematic review of observational studies. Nutr J. 2021;20(1):24.
Perez-Pardo P, Kliest T, Dodiya HB, et al. The gut-brain axis in Parkinson's disease: possibilities for food-based therapies. Eur J Pharmacol. 2017;15(817):86-95.
Castelli V, d'Angelo M, Quintiliani M, Benedetti E, Cifone MG, Cimini A. The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson's disease? Neural Regen Res. 2021;16(4):628-634.
Dogra N, Mani RJ, Katare DP. The gut-brain axis: two ways signaling in Parkinson's disease. Cell Mol Neurobiol. 2022;42(2):315-332.
Heinzel S, Aho VTE. Gut microbiome signatures of risk and prodromal markers of Parkinson disease. Ann Neurol. 2021;90(3):E1-E12.
Miranda-Díaz AG, García-Sánchez A. Foods with potential prooxidant and antioxidant effects involved in Parkinson's disease. Oxid Med Cell Longev. 2020;2020:6281454.
Gentile F, Doneddu PE, Riva N. Diet, microbiota and brain health: unraveling the network intersecting metabolism and neurodegeneration. Int J Mol Sci. 2020;21(20):7471.
Park HA, Ellis AC. Dietary antioxidants and Parkinson's disease. Antioxidants. 2020;9(7):570.
Goyal A, Verma A, Agrawal N. Dietary phytoestrogens: neuroprotective role in Parkinson's disease. Curr Neurovasc Res. 2021;18(2):254-267.
Maraki MI, Yannakoulia M, Stamelou M, et al. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease. Mov Disord. 2019;34(1):48-57.
Dardiotis E, Kosmidis MH, Yannakoulia M, Hadjigeorgiou GM, Scarmeas N. The Hellenic longitudinal investigation of aging and diet (HELIAD): rationale, study design, and cohort description. Neuroepidemiology. 2014;43(1):9-14.
Anastasiou CA, Yannakoulia M, Kosmidis MH, et al. Mediterranean diet and cognitive health: initial results from the Hellenic longitudinal investigation of ageing and diet. PloS One. 2017;12(8):e0182048.
Giagkou N, Maraki MI, Yannakoulia M, et al. A prospective validation of the updated Movement Disorders Society research criteria for prodromal Parkinson's disease. Mov Disord. 2020;35(10):1802-1809.
Buchman AS, Boyle PA, Wilson RS, Fleischman DA, Leurgans S, Bennett DA. Association between late-life social activity and motor decline in older adults. Arch Intern Med. 2009;169(12):1139-1146.
Mamalaki E, Anastasiou CA, Kosmidis MH, et al. Social life characteristics in relation to adherence to the Mediterranean diet in older adults: findings from the Hellenic longitudinal investigation of aging and diet (HELIAD) study. Public Health Nutr. 2020;23(3):439-445.
Kokouva M, Bitsolas N, Hadjigeorgiou GM, Rachiotis G, Papadoulis N, Hadjichristodoulou C. Pesticide exposure and lymphohaematopoietic cancers: a case-control study in an agricultural region (Larissa, Thessaly, Greece). BMC Public Health. 2011;11:5.
Bountziouka V, Bathrellou E, Giotopoulou A, et al. Development, repeatability and validity regarding energy and macronutrient intake of a semi-quantitative food frequency questionnaire: methodological considerations. Nutr Metab Cardiovasc Dis. 2012;22(8):659-667.
McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65(12):1863-1872.
Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis. 2006;16(8):559-568.
Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015;30(12):1600-1611.
Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB. Update of the MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2019;34(10):1464-1470.
Mahlknecht P, Gasperi A, Willeit P, et al. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community. Mov Disord. 2016;31(9):1405-1408.
Bougea A, Maraki MI, Yannakoulia M, et al. Higher probability of prodromal Parkinson disease is related to lower cognitive performance. Neurology. 2019;92(19):e2261-e2272.
Ntanasi E, Maraki M, Yannakoulia M, et al. Frailty and prodromal Parkinson's disease: results from the HELIAD study. J Gerontol A Biol Sci Med Sci. 2020;76(4):622-629.
Pachi I, Maraki MI, Giagkou N, et al. Late life psychotic features in prodromal Parkinson's disease. Parkinsonism Relat Disord. 2021;86:67-73.
Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson's disease. Mov Disord. 2014;29(4):454-462.
Sánchez-Villegas A, Martínez-González MA, Estruch R, et al. Mediterranean dietary pattern and depression: the PREDIMED randomized trial. BMC Med. 2013;11:208.
Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013;74(4):580-591.
Charisis S, Ntanasi E, Yannakoulia M, et al. Mediterranean diet and risk for dementia and cognitive decline in a Mediterranean population. J Am Geriatr Soc. 2021;69(6):1548-1559.
Zhang X, Xu J, Liu Y, Chen S, Wu S, Gao X. Diet quality is associated with prodromal Parkinson's disease features in Chinese adults. Mov Disord. 2022;37(12):2367-2375.
Agarwal P, Wang Y, Buchman AS, Holland TM, Bennett DA, Morris MC. MIND diet associated with reduced incidence and delayed progression of Parkinsonism A in old age. J Nutr Health Aging. 2018;22(10):1211-1215.
Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;86(5):1486-1494.
Liu YH, Jensen GL, Na M, et al. Diet quality and risk of Parkinson's disease: a prospective study and meta-analysis. J Parkinsons Dis. 2021;11(1):337-347.
Saaksjarvi K, Knekt P, Lundqvist A, et al. A cohort study on diet and the risk of Parkinson's disease: the role of food groups and diet quality. Br J Nutr. 2013;109(2):329-337.
Féart C, Samieri C, Allès B, Barberger-Gateau P. Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc Nutr Soc. 2013;72(1):140-152.
Zhang X, Molsberry SA, Schwarzschild MA, Ascherio A, Gao X. Association of diet and physical activity with all-cause mortality among adults with Parkinson disease. JAMA Netw Open. 2022;5(8):e2227738.
Ritz BR, Paul KC. Recommending healthy diet and exercise to patients with Parkinson disease-no reason to hold back. JAMA Netw Open. 2022;5(8):e2227743.
Maraki MI, Stefanis L, Yannakoulia M, et al. Motor function and the probability of prodromal Parkinson's disease in older adults. Mov Disord. 2019;34(9):1345-1353.
Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009;72(5):432-438.
von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005;15(4):473-490.
Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3-9.
Gu Y, Scarmeas N. Dietary patterns in Alzheimer's disease and cognitive aging. Curr Alzheimer Res. 2011;8(5):510-519.

Auteurs

Maria I Maraki (MI)

Department of Nutrition and Dietetics, School of Health Sciences, Hellenic Mediterranean University, Crete, Greece.
Section of Sport Medicine and Biology of Exercise, School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Athens, Greece.

Mary Yannakoulia (M)

Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.

Georgia Xiromerisiou (G)

School of Medicine, University of Thessaly, Larissa, Greece.

Leonidas Stefanis (L)

Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Greece.

Sokratis Charisis (S)

First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Greece.
Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Nikolaos Giagkou (N)

First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Greece.

Mary H Kosmidis (MH)

Laboratory of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Efthimios Dardiotis (E)

School of Medicine, University of Thessaly, Larissa, Greece.

Georgios M Hadjigeorgiou (GM)

Department of Neurology, Medical School, University of Cyprus.

Paraskevi Sakka (P)

Athens Association of Alzheimer's Disease and Related Disorders, Marousi, Greece.

Nikolaos Scarmeas (N)

First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Greece.
Department of Neurology, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, Columbia University, New York, USA.

Maria Stamelou (M)

First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Greece.
Parkinson's Disease and Movement Disorders Department HYGEIA Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH